With the recent emergence of next-generation-sequencing (NGS) analyses, concomitant somatic genomic alterations have been identified in samples of BRAF mutant melanomas [6,7,8,9], such as CDKN2A, PTEN, RAC1, and TERT promoter [10]. Here, BRAF is linked to melanoma.